Bristol Myers Squibb Company IP News and Updates

In the pharmaceutical industry, innovation drives progress, but intense legal battles, particularly in ANDA (Abbreviated New Drug Application) litigation, shape...

Revlimid (lenalidomide), developed by Celgene Corporation, has been a groundbreaking treatment for multiple myeloma, myelodysplastic syndromes, and mantle cell lymphoma...

As the relentless march of time continues, pharmaceutical executives find themselves facing the inevitability of patent expirations and the subsequent...

In August, our much-anticipated fourth annual ANDA Litigation Intelligence Report made its entrance into the world of pharmaceutical litigation. This...

Last August, we published our third annual ANDA Litigation Intelligence Report. The report covered the ANDA litigation landscape and focused...

In late August we released our third annual ANDA Litigation Intelligence Report. The report covered the ANDA litigation landscape by...

CASE OF THE WEEK Athena Diagnostics, Inc. v. Mayo Collaborative Services, LLC, Appeal No. 2017-2508 (Fed. Cir. Feb. 6, 2019)...

Federal Circuit Summary Before Newman, Dyk, and Chen.  Appeal from the Patent Trial and Appeal Board. Summary: An injury-in-fact is...